-transparent.png){kind=logo}
Adult respiratory distress syndrome (ARDS) remains a significant cause of morbidity and mortality in surgical practice. Despite the continued advance of surgical technique and therapy, the mainstay of treatment of ARDS remains supportive. In the past decade cytokines have been found to be primary chemical mediators of the host response to inflammatory disease. The polymorphonuclear leucocyte has also emerged as a possible cellular mediator of the end-organ damage that characterizes these inflammatory processes. The role of the neutrophil as the primary cellular mediator of alveolar capillary membrane injury in ARDS remains controversial. This article reviews the relevant current literature and considers the implications of the prevailing evidence on future management of this syndrome.
A C Windsor, and
P G Mullen, and
A A Fowler, and
H J Sugerman
January 2002,
The European journal of surgery = Acta chirurgica,
A C Windsor, and
P G Mullen, and
A A Fowler, and
H J Sugerman
August 1995,
American journal of respiratory cell and molecular biology,
A C Windsor, and
P G Mullen, and
A A Fowler, and
H J Sugerman
May 1981,
The New England journal of medicine,
A C Windsor, and
P G Mullen, and
A A Fowler, and
H J Sugerman
September 1989,
Mayo Clinic proceedings,
A C Windsor, and
P G Mullen, and
A A Fowler, and
H J Sugerman
January 1984,
Critical care medicine,
A C Windsor, and
P G Mullen, and
A A Fowler, and
H J Sugerman
November 1993,
New horizons (Baltimore, Md.),
A C Windsor, and
P G Mullen, and
A A Fowler, and
H J Sugerman
September 1993,
Zhonghua nei ke za zhi,
A C Windsor, and
P G Mullen, and
A A Fowler, and
H J Sugerman
October 1984,
Chest,
A C Windsor, and
P G Mullen, and
A A Fowler, and
H J Sugerman
September 2019,
British medical bulletin,
A C Windsor, and
P G Mullen, and
A A Fowler, and
H J Sugerman
May 1983,
The Medical clinics of North America,
